AVONEX
Expert Q & A
Q: Can you tell me the differences in benefits of ... more »
|
|||||
|
Multiple Sclerosis Info
|
Wednesday, October 31
AVONEX Q & A
by
multiplesclerosis
on Wed 31 Oct 2007 10:00 AM CST
Choosing a Multiple Sclerosis Treatment
by
multiplesclerosis
on Wed 31 Oct 2007 09:00 AM CST
Choosing a Multiple Sclerosis Treatment
Choosing the right multiple sclerosis (MS) treatment is an important step toward taking control of your multiple sclerosis. When ... more »
Tysabri (natalizumab) – study how Tysabri effects quality of life in multiple sclerosis
by
multiplesclerosis
on Wed 31 Oct 2007 09:00 AM CST
Tysabri (natalizumab) – study how Tysabri effects quality of life in multiple sclerosis
Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland ... more »
Stem Cell Therapies- International Distribution System
by
multiplesclerosis
on Wed 31 Oct 2007 07:59 AM CST
Vavici™ Announces Formation of First Comprehensive International Distribution System for Stem Cell Therapies NEW YORK--(BUSINESS WIRE)— Vavici has announced its plans to create ... more »
Tysabri - when stopping using there is increase disease activity
by
multiplesclerosis
on Wed 31 Oct 2007 07:57 AM CST
Disease Activity Increases After MS Patients Stop Natalizumab (Tysabri) Treatment ST. PAUL, MN -- September 12, 2007 -- People with multiple sclerosis (MS) who ... more »
ATL1102 Phase IIa Multiple Sclerosis Trial Update
by
multiplesclerosis
on Wed 31 Oct 2007 12:00 AM CST
ATL1102 Phase IIa Multiple Sclerosis Trial Update Tuesday, October 30
Disease Benefit with HE3286 in Model of Multiple Sclerosis
by
multiplesclerosis
on Tue 30 Oct 2007 08:00 AM CST
Monday, October 29
VITAMIN D SUPPLEMENTS
by
multiplesclerosis
on Mon 29 Oct 2007 11:50 AM CST
VITAMIN D SUPPLEMENTS APPEAR TO BE ASSOCIATED WITH LOWER RISK OF DEATH CHICAGO—Individuals who take vitamin D supplements appear to have a lower risk of ... more » Sunday, October 28
COPAXONE® Had Significantly Lower Risk of Relapse than Patients Using Rebif®
by
multiplesclerosis
on Sun 28 Oct 2007 12:00 AM CST
Study Showed Patients Using COPAXONE® Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif® in Relapsing-Remitting Multiple Sclerosis (RRMS)... more » Saturday, October 27
Acne Medication May Delay Progress of Multiple Sclerosis
by
multiplesclerosis
on Sat 27 Oct 2007 08:18 AM CST
Multiple Sclerosis Society of Canada Oct 25, 2007 12:30 ET Multiple Sclerosis Society of Canada: Acne Medication May Delay Progress of Multiple Sclerosis
COPAXONE® is More Cost Effective Than Tysabri®
by
multiplesclerosis
on Sat 27 Oct 2007 07:51 AM CST
New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE® is More Cost Effective Than Tysabri® for Treatment of Relapsing-Remitting Multiple Sclerosis Markov Model ... more » Thursday, October 11
Treating and preventing the flu
by
multiplesclerosis
on Thu 11 Oct 2007 12:00 AM CST
Treating and preventing the flu The normal treatment for flu is rest, plenty of liquids, and ASA* or acetaminophen to fight fever. Children ... more » Wednesday, October 10
Fatigue - insidious symptoms of MS
by
multiplesclerosis
on Wed 10 Oct 2007 09:10 AM CST
Over-exertion is often tied up with the work you do. Many people find that their job is simply not compatible with having MS. For example, a surveyor could not continue to climb up on roofs or balance along parapet walls. Two journalists could not carry on rushing about everywhere and meeting tight deadlines; a pilot had to forget about flying planes. The list is endless.
Once you have MS, your ‘energy cake’ is much smaller, and more »
Avascular Necrosis (AVN)
by
multiplesclerosis
on Wed 10 Oct 2007 09:07 AM CST
Avascular Necrosis (AVN) Introduction Avascular necrosis is the death of bone tissue due to a lack of blood supply. This can lead to ... more »
Imaging in multiple sclerosis
by
multiplesclerosis
on Wed 10 Oct 2007 09:06 AM CST
Imaging in multiple sclerosisNMR Research Unit, Department of Neuro-inflammation, Institute of Neurology, University College London, London, UK Multiple Sclerosis (MS) is a ... more » |
||||